Portfolio company
Bullseye Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Bullseye Biosciences
The company develops a drug discovery platform using robotics and directed evolution to create medicines for oncology, immunology and cardiometabolic diseases.
Oria Bioscience
This company provides isolated biological organelles to pharmaceutical firms and researchers for drug discovery and high-throughput screening applications.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Parallel Bio
This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.
AIM Biotech
This company develops organ-on-a-chip microfluidic platforms and research services for pharmaceutical firms and academic researchers to conduct preclinical human-tissue drug testing.
